3-HO-PCE

3-HO-PCE
Clinical data
Other names3-HO-PCE; 3-Hydroxyeticyclidine; Hydroxyeticyclidine
Drug classDissociative; Hallucinogen
ATC code
  • None
Legal status
Legal status
  • DE: NpSG (Industrial and scientific use only)
  • UK: Class B
  • Illegal in Turkey and Switzerland
Identifiers
  • 3-[1-(Ethylamino)cyclohexyl]phenol
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H21NO
Molar mass219.328 g·mol−1
3D model (JSmol)
  • CCNC1(CCCCC1)c1cccc(O)c1
  • InChI=1S/C14H21NO/c1-2-15-14(9-4-3-5-10-14)12-7-6-8-13(16)11-12/h6-8,11,15-16H,2-5,9-10H2,1H3
  • Key:MIKNPNLBFHVMKK-UHFFFAOYSA-N

3-Hydroxyeticyclidine (3-HO-PCE) is a novel dissociative drug of the arylcyclohexylamine class, related to phencyclidine. It was first identified as a novel psychoactive substance in Sweden in 2017, and has subsequently been sold online as a research chemical. The toxicity and long-term safety profile of 3-HO-PCE is unknown as it has a very limited history of use.